Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
They do not establish sterility, endotoxin status, receptor activity, hormone effects, safety, effectiveness, or approved use
People lost an average of 15% and up to 22.5% of their body weight, respectively
In the SURMOUNT-1 trial , participants receiving the highest dose of Tirzepatide achieved average body weight reductions of 20.9% over 72 weeks, compared to the 14.9% reduction observed with Semaglutide in the STEP-1 trial
MEDVi offers 24/7 messaging support for questions about side effects , injection technique, or dosing concerns
US$ 22.10
US$ 28.81
US$ 20.90
US$ 28.18
US$ 29.67
US$ 21.20
US$ 23.75
US$ 25.64
US$ 25.37
